Ribeiro Guilherme S, Lima Josilene B T, Reis Joice N, Gouveia Edilane L, Cordeiro Soraia M, Lobo Tatiana S, Pinheiro Ricardo M, Ribeiro Cássio T, Neves Alan B, Salgado Kátia, Silva Hagamenon R, Reis Mitermayer G, Ko Albert I
Gonçalo Moniz Research Center, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rua Waldemar Falcão 121, Bahia 40296-710, Salvador, Brazil.
Vaccine. 2007 May 30;25(22):4420-8. doi: 10.1016/j.vaccine.2007.03.024. Epub 2007 Mar 30.
The long-term impact of Haemophilus influenzae type b (Hib) conjugate vaccine, introduced throughout Latin America in the late 1990s, has not been evaluated. Active surveillance for H. influenzae meningitis was performed from August 9, 1996 to August 8, 2004 in Metropolitan Salvador, Brazil. Five years after the introduction of Hib conjugate vaccine, Hib meningitis incidence decreased from 2.39 to 0.06 cases per 100,000 population (98%) overall, and from 60.9 to 3.1 cases per 100,000 population (95%) in children <1 year of age. A transient serotype replacement phenomenon was observed associated with a small increase of meningitis due to two H. influenzae type a clonal groups. These findings indicate that Hib immunization campaign has led to the virtual elimination of Hib disease in this region.
20世纪90年代末在拉丁美洲各地推广的b型流感嗜血杆菌(Hib)结合疫苗的长期影响尚未得到评估。1996年8月9日至2004年8月8日在巴西萨尔瓦多市进行了流感嗜血杆菌脑膜炎的主动监测。引入Hib结合疫苗五年后,Hib脑膜炎发病率总体上从每10万人口2.39例降至0.06例(下降98%),1岁以下儿童从每10万人口60.9例降至3.1例(下降95%)。观察到一种短暂的血清型替代现象,与两个甲型流感嗜血杆菌克隆群导致的脑膜炎小幅增加有关。这些发现表明,Hib免疫接种运动已导致该地区Hib疾病几乎消除。